Eurostars
Description
Eurostars is a prominent European joint programme dedicated to stimulating research and development (R&D) performing small and medium-sized enterprises (SMEs). Operating under the umbrella of the Eureka network, Eurostars provides grants, rather than traditional venture capital equity investments, to foster international collaborative R&D and innovation projects. The programme is 'bottom-up,' meaning it has no thematic restrictions, allowing SMEs from various sectors to apply for funding for their innovative ideas.
This funding mechanism is designed to support market-driven R&D projects that lead to new products, processes, or services. Projects must involve at least two participants from two different Eurostars countries, with R&D-performing SMEs playing a central role. The programme aims to accelerate the commercialization of innovative solutions by providing financial support for the critical R&D phase, thereby reducing the financial burden on SMEs and encouraging cross-border collaboration.
Funding for Eurostars projects is provided by national funding bodies within participating countries, which means the exact grant amounts and funding rates can vary. However, the programme provides general guidelines and averages. The average grant awarded per project is approximately €370,000, equivalent to about $399,600 USD. The typical maximum funding per project can reach around €500,000, or approximately $540,000 USD, though this is subject to national variations. While there isn't a universally stated minimum grant, typical projects receiving Eurostars support are substantial, suggesting that the smallest typical grant would be a significant sum to support international R&D efforts.
Eurostars plays a crucial role in the European innovation ecosystem by enabling SMEs to overcome financial hurdles and access international expertise. Its focus on grants rather than equity allows companies to retain full ownership of their intellectual property, making it an attractive funding option for R&D-intensive businesses looking to scale their innovations globally. The programme has supported thousands of projects, contributing significantly to technological advancements and economic growth across Europe.
Investor Profile
Eurostars has backed more than 100 startups, with 8 new investments in the last 12 months alone. The firm has led 69 rounds, about 69% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Series Unknown, Seed rounds (top funding stages).
- Majority of deals are located in Switzerland, Lithuania, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 8 rounds in the past year.
- Typical check size: $162K – $540K.
Stage Focus
- Grant (96%)
- Series Unknown (1%)
- Seed (1%)
- Series A (1%)
- Pre Seed (1%)
Country Focus
- Switzerland (34%)
- Lithuania (15%)
- The Netherlands (10%)
- Sweden (8%)
- United Kingdom (7%)
- Spain (4%)
- Denmark (4%)
- France (4%)
- Germany (4%)
- United States (2%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Manufacturing
- Life Science
- Medical Device
- Pharmaceutical
- Software
- Artificial Intelligence (Ai)
- Therapeutics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.